SNDX Competitors & Alternatives
Compare Syndax Pharmaceuticals Inc with similar stocks in the same industry
Biotechnology
SNDX
Main Stock$19.24
Tradestie Score
59
Market Cap
$1.35B
Revenue Growth
2.2%
Analyst Upside
+105.1%
Top Competitors
227 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
IMCR
Immunocore Holdings plc American Depositary Shares
|
$32.43
|
$1.81B | - | 51 | Compare |
|
ABCL
AbCellera Biologics Inc. Common Shares
|
$5.83
|
$1.78B | - | 55 | Compare |
|
DYN
Dyne Therapeutics, Inc. Common Stock
|
$25.24
|
$1.78B | - | 55 | Compare |
|
VRDN
Viridian Therapeutics, Inc. Common Stock
|
$19.31
|
$1.74B | - | 56 | Compare |
|
CLDX
Celldex Therapeutics, Inc
|
$37.69
|
$1.68B | - | 57 | Compare |
|
MNKD
Mannkind Corporation
|
$3.80
|
$1.65B | - | 51 | Compare |
|
EWTX
Edgewise Therapeutics, Inc. Common Stock
|
$38.38
|
$1.63B | - | 50 | Compare |
|
BHVN
Biohaven Ltd.
|
$13.37
|
$1.57B | - | 51 | Compare |
|
VCEL
Vericel Corporation
|
$46.05
|
$1.56B | 95.8 | 52 | Compare |
|
DNTH
Dianthus Therapeutics, Inc. Common Stock
|
$106.02
|
$1.55B | - | 56 | Compare |
More SNDX Analysis
Data updated: Aug 03, 2026 | Industry: Biotechnology (SIC 2834)
227 stocks in this industry